Roshni Dasgupta · What is new in pediatric surgical oncology?
Follow
Article1 min read·Published Jan 2017Older

What is new in pediatric surgical oncology?

pubmed.ncbi.nlm.nih.gov shows its articles on its own site.

Read the article on pubmed.ncbi.nlm.nih.gov ↗

Article · Jan 2017 · 1 min read

In brief

In brief

This review synthesizes recent advances in pediatric surgical oncology protocols and techniques across common solid tumors. Key developments include sentinel lymph node mapping for sarcomas, nonoperative management strategies for neuroblastoma, quality metrics for Wilms tumor surgery, and international collaborative trials for rare tumors like germ cell and liver malignancies.

Written by the GCMD Library team from the article.

Roshni Dasgupta

Purpose Of Review: As pediatric oncology has become more complex, designing and maintaining pediatric surgical protocols require greater expertise. The primary purpose of this review is to summarize the changes in protocols and new study findings, which have changed surgical practice for children with solid tumors. Recent Findings: The most common solid tumors treated by surgery are reviewed. There are new methods of surgical techniques such as the use of sentinel lymph node techniques for the assessment of lymph nodes in pediatric sarcoma. New studies showing excellent outcomes for the nonoperative treatment for young patients with neuroblastoma are discussed. Surgical quality with the prevention of tumor rupture and the assessment of lymph nodes is essential for good outcomes in patients with Wilm's tumor. The international collaborations within germ cell and liver tumors have provided excellent new study regimens and welcomed a new era of studies that are robust and have the power to change the outcomes for these rare tumors. Summary: Surgical practice is evolving with the molecular advances in pediatric oncology. Technical advances and quality improvement endeavors to ensure protocol adherence are essential. International partnerships have allowed for greater advances particularly for rare tumors and improve overall surgical outcomes.

Read it at the source ↗

Try
Intelligent Search· scoped to this article · not medical adviceSearch the whole library →